Treatment with the aromatase inhibitor letrozole during adolescence increases near‐final height in boys with constitutional delay of puberty

@article{Hero2006TreatmentWT,
  title={Treatment with the aromatase inhibitor letrozole during adolescence increases near‐final height in boys with constitutional delay of puberty},
  author={M. Hero and S. Wickman and L. Dunkel},
  journal={Clinical Endocrinology},
  year={2006},
  volume={64}
}
Objective  We investigated whether inhibition of oestrogen biosynthesis with the aromatase inhibitor, letrozole, during adolescence improves near‐final height in boys with constitutional delay of puberty. 
Aromatase inhibitors in men: effects and therapeutic options
TLDR
Long-term efficacy and safety of the use of aromatase inhibitors has not yet been established in males, however, and their routine use is therefore not yet recommended. Expand
Aromatase inhibitors in men: effects and therapeutic options
TLDR
Long-term efficacy and safety of the use of aromatase inhibitors has not yet been established in males, however, and their routine use is therefore not yet recommended. Expand
Use of Aromatase Inhibitors in Children and Adolescents With Disorders of Growth and Adolescent Development
Although treatment of children and adolescents who have disorders of growth and adolescent development with aromatase inhibitors is increasingly common, data for or against their use are extremelyExpand
Use of aromatase inhibitors in children and adolescents: what's new?
TLDR
Third-generation aromatase inhibitors in combination with antiandrogen appear effective in preventing bone age advancement and virilization in boys with familial male-limited precocious puberty (FMPP). Expand
Letrozole as a booster therapy in growth hormone deficiency.
TLDR
A 13 year old boy presented to us with short stature and was treated with GH replacement for 10 months and an aromatase inhibitor Letrozole was added to GH therapy to boost up the growth potential. Expand
Therapeutic uses of aromatase inhibitors in men.
TLDR
Aromatase inhibitors effectively delay epiphysial maturation in boys and improve testosterone levels in adult men and may be used to increase adult height in boys with pubertas praecox, idiopathic short stature and constitutional delay of puberty. Expand
Letrozole versus testosterone for promotion of endogenous puberty in boys with constitutional delay of growth and puberty: a randomised controlled phase 3 trial.
TLDR
Letrozole might be a feasible alternative treatment to low-dose testosterone for boys with CDGP who opt for medical intervention, however, the risks and benefits of manipulating the reproductive axis during early puberty should be weighed carefully. Expand
Update on the Role of Aromatase Inhibitors in Growth Disorders
  • L. Dunkel
  • Medicine
  • Hormone Research in Paediatrics
  • 2009
TLDR
Long-term follow-up data from the study in which boys with CDGP were treated with letrozole for 1 year during adolescence suggest that the achieved gain in predicted adult height also results in taller final adult height. Expand
Aromatase Inhibitors and Growth Disorders
TLDR
Long-term follow-up data of boys with constitutional delay of puberty, treated with letrozole for 1 year during adolescence, suggest that the achieved gain in predicted adult height also results in taller adult height. Expand
Effect of letrozole on the predicted adult height in boys with constitutional delay of growth and puberty: A clinical trial
TLDR
The study provides an indication for the treatment with letrozole (aromatase inhibitors) increase PAH with slowing the progression of bone age and letroZole has no adverse effects on bone metabolism and serum lipids. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 24 REFERENCES
A specific aromatase inhibitor and potential increase in adult height in boys with delayed puberty: a randomised controlled trial
TLDR
The findings suggest that if oestrogen action is inhibited in growing adolescents, adult height will increase, and provides a rationale for studies that aim to delay bone maturation in several growth disorders. Expand
Inhibition of estrogen biosynthesis with a potent aromatase inhibitor increases predicted adult height in boys with idiopathic short stature: a randomized controlled trial.
TLDR
Treatment with the aromatase inhibitor Lz delays bone maturation and improves PAH in boys with idiopathic short stature and no adverse effects on bone mineralization were evident after 2 yr of treatment. Expand
Serum androgen bioactivity in adolescence: a longitudinal study of boys with constitutional delay of puberty.
TLDR
It is suggested that circulating androgen bioactivity mediates the tempo of pubertal maturation and that the combination of testosterone and letrozole given to boys with constitutional delay of puberty accelerates puberty. Expand
Treatment with a luteinizing hormone-releasing hormone agonist in adolescents with short stature.
TLDR
A randomized clinical trial to determine whether treatment with an LHRH agonist increases adult height in short adolescents with normally timed puberty. Expand
Treatment with a luteinizing hormone-releasing hormone agonist in adolescents with short stature.
TLDR
Treatment with an LHRH agonist for 3.5 years resulted in significantly greater adult height than did placebo in boys and girls, in adolescents with idiopathic short stature, and in those who had a growth-limiting syndrome. Expand
The role of estrogen in bone growth and maturation during childhood and adolescence
  • G. Cutler
  • Biology, Medicine
  • The Journal of Steroid Biochemistry and Molecular Biology
  • 1997
TLDR
It is concluded that the pubertal growth spurt of both sexes is driven primarily by estrogen, and that the more rapid epiphyseal maturation of prepubertal girls (vs boys) may be explained by their higher estradiol levels. Expand
An Open Label 12-Month Pilot Trial on the Effects of the Aromatase Inhibitor Anastrozole in Growth Hormone (GH)-Treated GH Deficient Adolescent Boys
TLDR
Anastrozole treatment potently decreases estrogen concentrations in adolescent males with GHD while allowing normal virilization, without deleterious effects on body composition, plasma lipids, bone metabolism or the tempo of puberty. Expand
Predictive factors in the determination of final height in boys with constitutional delay of growth and puberty.
TLDR
It is concluded that a late onset in the timing of puberty seems to be deleterious to spinal growth and consequently to final height attainment, and an alternative therapeutic approach may be required in patients with features of constitutional delay of growth and puberty. Expand
Long-term testolactone therapy for precocious puberty in girls with the McCune-Albright syndrome.
TLDR
It is concluded that testolactone can be effective in the treatment of LHRH-independent precocious puberty in girls with McCune-Albright syndrome, but that some patients exhibit an escape from the effects of treatment after 1-3 yr. Expand
Final height in boys with untreated constitutional delay in growth and puberty.
TLDR
It is shown that although boys with CDGP reach their predicted heights, this is short for their families, and the more frequent use of active medical treatment to advance growth is supported. Expand
...
1
2
3
...